News | October 16, 2025
Syngene International invests in peptide laboratory in Bengaluru
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
Subscribe To Our Newsletter & Stay Updated
